AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.

Patent protection in the biotechnology industry: a unique approach to obtaining fast patent rights.

Intellectual Property & Technology Law Journal

| August 01, 2006 | Burow, Scott A.; Berghammer, Joseph J. | COPYRIGHT 2003 Aspen Publishers, Inc. (Hide copyright information)Copyright

Strong intellectual property protection is as essential in the biotechnology field as in any other cutting-edge field. Biotechnology patents can serve to promote the advancement of new medicines, diagnostic equipment, and agricultural products. Biotechnology patents not only reward inventors for their inventions through market exclusivity, they also can stimulate research and the flow of scientific and technological knowledge on a global basis. Biotechnology patents further encourage companies to invest in developing new drugs, therapies, and equipment. This development often takes many years and is a very expensive and risky process. Without patent protection, competitors could copy the developed drugs, for example, and sell these drugs at a substantially lower price because they have not expended the resources necessary to develop the drugs. In this situation, the competitor could capture a substantial portion of the market with a lower priced drug and the innovating company would be required to lower its price to compete and, as a result, may never recoup its substantial development costs. Thus, it becomes critical to obtain patent protection and to do so as expeditiously as possible. This article addresses a unique approach to obtaining fast patent protection to help companies capture or maintain market share and exclusivity and prevent would-be copiers from undercutting the substantial investment expended by these companies.

Biotechnology-derived products have the potential to positively change our society, from improving health care to creating a cleaner, safer environment. Recent developments such as the sequencing of the human genome provide a foundation that will support decades of research, discovery, and development. Indeed, the markets recognize this potential, and as a result, significant investment has flowed into …

Related articles from newspapers, magazines, journals, and more
A Bill full of promises. (The biotechnology industry in India recorded a 20...
Magazine article from: India Business Insight May 15, 2012 700+ words
Hailing the end of patent nonsense; industry cheers new loosening of patent...
Magazine article from: San Francisco Business Times Davey, Tom January 13, 1995 700+ words
Biotechnology and Intellectual Property Discussion to Be Held at Stanford Law...
News wire article from: Europe Intelligence Wire March 7, 2005 700+ words
Industry urges court to reject patent test.
News wire article from: Chemical Business Newsbase August 17, 2009 700+ words
FDA caution tempers race for generic biologics: Europe bests the United...
Magazine article from: The Scientist Warner, Susan October 20, 2003 700+ words
©2013 Gale, a part of Cengage Learning. All rights reserved. Contact us | Privacy policy | Terms and conditions

The AccessMyLibrary advertising network includes: womensforum.com GlamFamily